Interaction between Enalapril and Aspirin on mortality after acute myocardial infarction: Subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

American Journal of Cardiology

Volumn 79, Issue 2, 1997, Pages 115-119

  Nguyen, Khang Ngoc ^a   Aursnes, Ivar ^b   Kjekshus, John ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

AGED; ARTICLE; CAUSE OF DEATH; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ANTAGONISM; DRUG INTERACTION; FEMALE; FOLLOW UP; FORECASTING; HEART INFARCTION; HUMAN; MALE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCANDINAVIA; STATISTICAL MODEL; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CAUSE OF DEATH; CONFIDENCE INTERVALS; DOUBLE-BLIND METHOD; DRUG INTERACTIONS; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HEART FAILURE, CONGESTIVE; HUMANS; LOGISTIC MODELS; MALE; MYOCARDIAL INFARCTION; PLACEBOS; RECURRENCE; RETROSPECTIVE STUDIES; SCANDINAVIA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031567879     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00696-0     Document Type: Article

References (14)

1. Antiplatet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81-106.
2. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L, Wedel H. Effects of early administration of enalpril on mortality in patients with acute myocardial infarction: results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). New Engl J Med 1992;327:678-684.
3. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-828.
4. Gruppo Italiano per Io Studio della Soprawivenza nell'infarcto Miocardio. GISSI-3: effects of lisinopril and transdermal glyceryl tri nitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-1122.
5. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr., Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. New Engl J Med 1992;327:669-677.
6. Ambrosioni E, Borghi C, Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. New Engl J Med 1995;332:80-85.
7. Fourth International Study of Infarct Survival (ISIS-4) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
8. Chinese Cardiac Study Collaborative Group. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet 1995; 345:686-687.
9. Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videbæk J, Cole DS, Auclert L, Pauly NC et al for the Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333: 1670-1676.
10. Hall D, Zeitler H, Rudolph W. Counteraction of the vasodilator effects of enalapril by aspiring in severe heart failure. J Am Coll Cardiol 1992;20:1549-1555.
11. Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan K, Fagan RF, Arner TG. Epi Info, Version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Centers for Disease Control and Prevention, Atlanta, GA, 1994.
12. SPSS Inc. SPSS/PC+ V3.0. Chicago, IL: SSS Inc., 1988.
13. Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol 1976;103:506-511.
14. Smith GD, Egger M. Who benefits from medical interventions? Treating low risk patients can be a high risk strategy. Br Med J 1994;308:72-74.